Quantcast

Posts related to ‘Amarin sell-off’

pills

Amarin Takes on More Debt, Shares Suffer

Biopharmaceutical company Amarin Corp. PLC (NASDAQ: AMRN) announced after markets closed last night that it has received $100 million in nonequity financing from an investment fund managed by Pharmakon Advisors. ...
Read Full Story »